Financials MEDI LIFE Singapore S.E.

Equities

5TN

SG2D67974808

Healthcare Facilities & Services

End-of-day quote Singapore S.E. 18:00:00 2024-02-01 EST 5-day change 1st Jan Change
0.011 SGD +10.00% Intraday chart for MEDI LIFE -8.33% -15.38%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 20.88 68.8 57.01 35.91 15.62 5.182
Enterprise Value (EV) 1 22.73 81.22 64.12 39.03 18.52 8.793
P/E ratio -1.22 x 119 x -20.3 x -1.39 x -3.48 x -0.55 x
Yield - - - - - -
Capitalization / Revenue 7.05 x 7.04 x 91.6 x 25.7 x 6.51 x 2.67 x
EV / Revenue 7.68 x 8.32 x 103 x 27.9 x 7.71 x 4.53 x
EV / EBITDA -3.23 x -11 x -6.64 x -7.42 x -3.26 x -1.4 x
EV / FCF 5.17 x -16.2 x -9.73 x -14 x -17.2 x -1.84 x
FCF Yield 19.3% -6.18% -10.3% -7.13% -5.8% -54.5%
Price to Book -2.05 x 20 x 7.49 x -6.06 x -1.79 x -0.56 x
Nbr of stocks (in thousands) 28,551 41,167 49,288 55,277 59,702 114,634
Reference price 2 0.7312 1.671 1.157 0.6496 0.2617 0.0452
Announcement Date 19-04-11 20-05-15 21-04-04 22-05-11 23-04-12 24-04-14
1MYR in Million2MYR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 2.961 9.768 0.6227 1.397 2.401 1.943
EBITDA 1 -7.045 -7.377 -9.66 -5.263 -5.689 -6.263
EBIT 1 -8.092 -8.053 -9.691 -5.348 -5.742 -6.348
Operating Margin -273.25% -82.44% -1,556.23% -382.72% -239.17% -326.72%
Earnings before Tax (EBT) 1 -8.642 -10.17 -10.47 -13.63 -4.331 -7.191
Net income 1 -17.05 0.4875 -2.763 -23.72 -4.303 -7.195
Net margin -575.81% 4.99% -443.78% -1,697.65% -179.21% -370.28%
EPS 2 -0.5973 0.0140 -0.0570 -0.4680 -0.0751 -0.0829
Free Cash Flow 1 4.395 -5.023 -6.591 -2.784 -1.074 -4.789
FCF margin 148.42% -51.43% -1,058.4% -199.22% -44.74% -246.46%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 19-04-11 20-05-15 21-04-04 22-05-11 23-04-12 24-04-14
1MYR in Million2MYR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 1.86 12.4 7.11 3.12 2.89 3.61
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -0.2638 x -1.683 x -0.7363 x -0.5924 x -0.5087 x -0.5765 x
Free Cash Flow 1 4.4 -5.02 -6.59 -2.78 -1.07 -4.79
ROE (net income / shareholders' equity) 370% 299% -190% -1,628% 58.8% 80.2%
ROA (Net income/ Total Assets) -13.3% -18.5% -23.6% -26.8% -116% -266%
Assets 1 127.9 -2.642 11.7 88.62 3.72 2.709
Book Value Per Share 2 -0.3600 0.0800 0.1500 -0.1100 -0.1500 -0.0800
Cash Flow per Share 2 0.0400 0.0700 0.0100 0.0200 0.0100 0
Capex 1 0.87 0.07 0.31 0.2 0.19 0.02
Capex / Sales 29.27% 0.68% 49.49% 14.14% 7.96% 1.28%
Announcement Date 19-04-11 20-05-15 21-04-04 22-05-11 23-04-12 24-04-14
1MYR in Million2MYR
Estimates